Boris Johnson’s recent announcement setting out his vision to cement UK as a science superpower, included some timely and reassuring words about the UK’s commitment to not only retaining and attracting world-class scientific talent, but also to continuing and increasing R&D funding support.
Quotes from the announcement included:
“In recognition of the huge value of science to the UK, particularly post-Brexit, in addition to immigration changes to support a reinvigorated research economy, the government will also provide additional funding for scientists and researchers who have sought EU funding before we leave. This includes schemes delivered by the European Research Council to ensure no-one is disadvantaged.
In the event we leave without a deal, the government will ensure any Horizon 2020 applications stuck in the approval process when the UK leaves, will instead be automatically reviewed by UKRI – with successful applications provided with funding.”
The Prime Minister also said:
“I want the UK to continue to be a global science superpower, and when we leave the EU we will support science and research and ensure that, far from losing out, the scientific community has a huge opportunity to develop and export our innovation around the world.”
Positive news – but it also reflects the increasing complexity of the UK R&D funding landscape as more and more types of solution are launched onto the market. For instance, in addition to Innovate UK and Horizon 2020 grants, we have recently seen, for example, Innovate UK loans, Innovate UK/Private equity investments, and advance funding against future R&D Tax Credit claims come into being over the last two years.
How do you decide which option is best for you?
MSC R&D live and breathe R&D and have the expertise, combined with 30 years’ experience, to help tech businesses navigate their way through this landscape – contact us on 0114 230 8401